Intermittent fasting demonstrates benefits across multiple physiological systems in animal and human studies. Although much research is in pre-clinical models, data suggest that intermittent fasting decreases inflammatory markers, improves insulin sensitivity and metabolic profiles, reduces cardiovascular risk, enhances cognition and sensory-motor function, and relieves symptoms of neurological and mood-related disorders.
The benefits of intermittent fasting directly target a number of mechanisms associated with different pain states and chronic pain conditions.
A 12-to-16-hour intermittent fasting regimen is simple to follow, easy to implement, cost-effective, and well-tolerated across diverse populations.
There is a need for clinical trials to be conducted in individuals with chronic pain implementing recognized fasting methods to promote improved interpretation, clear guidance for clinical application, and repeatability across studies.
Caution should be taken regarding fasting for high-risk individuals such as children, pregnant individuals, and the elderly.
Always discuss this type of fasting with your physician prior to starting intermittent fasting.
Comments